Involvement of the endocannabinoid system in drug addiction

  title={Involvement of the endocannabinoid system in drug addiction},
  author={Rafael Maldonado and Olga Valverde and Fernando Berrendero},
  journal={Trends in Neurosciences},

Figures and Tables from this paper

Drug addiction.

The cannabinoid CB(1) antagonist/inverse agonist rimonabant has been shown to reduce the behavioral effects of stimuli associated with drugs of abuse, including nicotine, alcohol, cocaine, and marijuana, and the endocannabinoid system represents a promising target for development of new treatments for drug addiction.

Role of endocannabinoids in regulating drug dependence

Preclinical and clinical studies suggest that the endocannabinoid system can be manipulated by the CB1 receptor antagonist SR141716A, that might constitute a new generation of compounds for treating addiction across different classes of abused drugs.

An Endocannabinoid Hypothesis of Drug Reward and Drug Addiction

  • E. Onaivi
  • Biology, Psychology
    Annals of the New York Academy of Sciences
  • 2008
The data provide strong new evidence for a role for EPCS modulation in the effects of drugs of abuse, and specifically for involvement of cannabinoid receptors in the neural basis of addiction.

Role of the endocannabinoid system in drug addiction.

An endocannabinoid hypothesis of drug reward

The EPCS may be important natural regulatory mechanism for reward and a target for the treatment of addictive disorders and there is accumulating evidence indicating a central role of endocannabinoid physiological control system in the regulation of the rewarding effects of abused substances.

Endocannabinoids and addiction memory: Relevance to Methamphetamine/Morphine Abuse.

The role of ECS in the modulation of METH/morphine-induced memory impairments is summarized to clarify the role of neurotransmitters in this regard.

The role of CB1 receptors in psychostimulant addiction

Results of studies using cannabinoid receptor subtype 1 (CB1) knockout mice as well as CB1 antagonists to elucidate the role of this neurotransmitter system in psychostimulant addiction suggest that modulators of the eCB system represent a promising novel type of therapy to treat drug addiction.

Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights

Recent advances on the understanding of the role of the different components of the cannabinoid system on nicotine’s effects are presented and possible alternative ways of modulating the cannabinoids system that could have implication for nicotine dependence treatment are suggested.



Cannabinoid CB1 receptors control conditioned drug seeking.

Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

Findings from both clinical and preclinical studies suggest that ligands blocking CB1 receptors offer a novel approach for patients suffering from drug dependence that may be efficacious across different classes of abused drugs.

Cannabinoid tolerance and dependence.

Recent advances that have increased understanding of the impact of chronic cannabinoid administration on cannabinoid receptors and their signal transduction pathways are described and several potential pharmacotherapies that have been examined to treat marijuana dependence are discussed.

Endocannabinoid Signaling in the Brain

The primary psychoactive ingredient in cannabis, Δ9-tetrahydrocannabinol (Δ9-THC), affects the brain mainly by activating a specific receptor (CB1) and suppressing neurotransmitter release.

Opioid System Involvement in Cannabinoid Tolerance and Dependence

Cannabis derivatives produce clear subjective motivational responses in humans, leading to drugseeking behavior and abuse, and some symptoms of abstinence in heavy users of strong cannabis preparations are described.

Study of cannabinoid dependence in animals.

Neurobiological mechanisms in the transition from drug use to drug dependence

Molecular mechanisms of drug addiction

  • E. Nestler
  • Biology, Psychology
  • 2004